# Ciro Spedaliere

> Ciro Spedaliere is a seed investor at Claris Ventures backing Biotechnology and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Claris Ventures](https://shizune.co/investors/profile/claris-ventures)
- Location: Torino, Italy
- Total investments: 3
- Last investment: Apr 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/cirospedaliere/
- X (Twitter): http://twitter.com/CiroSpedaliere
- Website: https://x.com/CiroSpedaliere

Ciro Spedaliere is a seed investor at Claris Ventures in Torino focused on Biotechnology and Health Care. Ciro Spedaliere - Partner @ Claris Ventures

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Health Care | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Medical | 1 | 33% |
| Life Science | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Iama Therapeutics | At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need. | $17.1M | Venture - Series Unknown | Apr 16, 2025 |  |
| Repron Therapeutics | Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely. | $2.1M | Seed | Jun 06, 2023 |  |
| Sibylla Biotech | Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas. | $23M | Series A | Oct 04, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund, 2 deals together
- [Indaco Venture Partners](https://shizune.co/investors/profile/indaco-venture-partners) — VC Fund, 2 deals together
- [ENEA Tech e Biomedical](https://shizune.co/investors/profile/enea-tech-e-biomedical) — VC Fund, 1 deal together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 1 deal together
- [Seroba Life Sciences](https://shizune.co/investors/profile/seroba-life-sciences) — VC Fund, 1 deal together
- [V-Bio Ventures](https://shizune.co/investors/profile/v-bio-ventures) — VC Fund, 1 deal together

## About Claris Ventures

VC Fund · Torino, Italy

Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies arisen from the Italian R&D ecosystem

3 contacts available at Claris Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Ciro Spedaliere | Partner | https://shizune.co/investors/profile/ciro-spedaliere |
| Barbara Castellano | Investment committee member | https://shizune.co/investors/profile/laura-iris-ferro |
| Lola Buono | Senior Associate | https://shizune.co/investors/profile/lola-buono |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ciro Spedaliere invest in?

Ciro Spedaliere invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ciro Spedaliere last invest?

The most recent investment recorded for Ciro Spedaliere closed in Apr 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co